Table 3. Crude and age-adjusted 5- and 10-year absolute survival of patients diagnosed with common forms of cancer above 14 years of age in Finland in 1989.

	5-year absolute survival					10-year absolute survival
		Age adjusted					Age adjusted
		PE		s.e.			PE		s.e.
Cancer site	Crude	T	A	T	A	Crude	T	A	T	A
Oral cavity	48.5	51.7	51.7	2.64	2.65	33.3	38.6	38.6	2.53	2.53
Stomach	17.1	17.3	17.3	1.16	1.17	13.0	13.2	13.1	1.03	1.03
Colon	40.2	39.7	39.7	1.55	1.54	29.9	29.4	29.4	1.42	1.41
Rectum	34.9	35.3	35.2	1.90	1.92	24.7	25.2	25.2	1.69	1.72
Pancreas	1.4	1.3	1.3	0.44	0.44	1.1	1.0	1.0	0.41	0.40
Lung	7.9	8.1	8.1	0.62	0.63	4.5	4.6	4.6	0.48	0.48
Breast	71.2	71.3	71.4	0.86	0.85	54.2	54.5	54.4	0.91	0.92
Cervix	49.0	62.6	62.6	3.99	3.99	42.1	57.2	57.3	3.95	3.92
Corpus	62.8	67.5	67.5	1.78	1.80	51.4	56.8	56.8	1.88	1.91
Ovaries	32.3	34.6	34.6	2.16	2.17	24.3	26.7	26.7	1.94	1.97
Prostate	42.6	42.8	42.8	1.36	1.35	19.1	19.1	19.1	1.06	1.06
Kidneys	44.8	46.3	46.3	2.02	2.02	32.6	34.3	34.3	1.88	1.88
Urinary bladder	49.2	50.6	50.6	1.82	1.85	31.6	33.2	33.2	1.66	1.67
Melanoma	71.3	73.5	73.4	1.88	1.90	59.0	62.1	62.0	2.03	2.04
Thyroid gland	77.2	74.9	75.0	2.26	2.23	72.8	70.4	70.4	2.25	2.21

Age adjustment is made to the site-specific EUROCARE-2 standard population. Point estimates (PE) and their standard errors (s.e.) obtained by bootstrap analyses with 10 000 replications are given for age adjustment by the traditional method (T) and by the alternative method (A).